Page 29 - ITPS-6-1
P. 29

23    INNOSC Theranostics and Pharmacological Sciences, 2023, Vol. 6, No. 1                  Kivrak, et al.
           on  different  clinical  features  as  initial  symptoms   components, causing skin hardening. Scleroderma-
           in its diagnosis, such as the presence of Raynaud    like  syndrome,  especially  diabetic  sclerodactyly
           phenomenon,  the  nail  bed  capillary  pattern,     as the most common skin manifestation of type 1
           proximal  or distal  cutaneous  changes, and the     DM, strongly  correlates  with  the  duration  of  the
           presence of autoantibodies [5], SSc can be divided   disease.  In  many  cases,  it  may  be  challenging
           into two types: SSc with limited skin involvement    to distinguish the histopathological  changes in
           and diffuse skin involvement. By referring to the    diabetic scleroderma-like syndrome from those in
           European League Against Rheumatism (EULAR)           the course of SSc [14].
           records, Minier et al. stated that puffy fingers are the   Cardiac  involvement  in  SSc may  lead  to
           main findings in the initial assessment of SSc [6].  high  morbidity  and mortality.  Therefore,  early
              Hypertension (HT), diabetes mellitus  (DM),       diagnosis and treatment are required. For instance,
           and renal diseases are the major systemic vascular   the  10-year  mortality  of patients  with  cardiac
           diseases  in  which  differences  can  be  observed   involvement in SSc is around 20%. Both primary
           in  the disease progression, presentation,  and      and secondary cardiac involvement may be present
           prognosis. The previous studies have shown that      in SSc. While primary involvement occurs due to
           the development of HT can be predicted in patients   the direct effect of inflammation on cardiac tissue,
           over 45 with high inflammatory markers and skin      secondary involvement is secondary to pulmonary
           involvement  [7]. HT causes vascular changes         hypertension.
           similar to those observed in SSc [8]. Perivascular      SSc may cause myocardial fibrosis and right and
           inflammatory  infiltrates,  impaired  angiogenesis,   left ventricular systolic and diastolic dysfunction,
           and endothelial  apoptosis are  all  observed in the   as well as pericardial and endocardial damages.
           early stages of the disease. Data from animal        Echocardiography is a contributory non-invasive
           models have shown  that prolonged, uncontrolled      test used to evaluate cardiac involvement. Through
           overexpression of vascular endothelial  growth       echocardiography, the left and right ventricular
           factor may have paradoxical effects on the formation   functions can be assessed, and pulmonary hypertension
           of new vessels, leading to capillary changes similar   can be detected with high sensitivity [15].
           to those observed in SSc. In addition to impaired       In this study, we aimed to investigate the clinical,
           angiogenesis,  defective  vasculogenesis  may        laboratory, and echocardiographic features of SSc
           contribute  to the vascular symptoms in SSc [9].     patients  in  our center, evaluate  the  proportion  of
           Cardiovascular  diseases are frequently  observed    patients  with cardiovascular disease ratio, and
           in patients with rheumatoid  joint  diseases and     compare them with other population-based studies
           individuals with SSc [10].                           in the Turkish population.
              Although the  relationship  between  SSc and
           pulmonary arterial hypertension (PAH) is known,      2. Methods
           idiopathic  PAH and PAH associated  with SSc         2.1. Study participants
           (SSc-PAH)  are  histologically  different  [11].
           SSc-PAH  is the most common form of PAH              In this study, 150  patients who were previously
           associated with connective tissue disease. SSc-PAH   diagnosed and treated  in the rheumatology
           is essential to all cases of PAH [12]. Approximately   clinic were included in the study. Their age, sex,
           12%–15% of patients with SSc are estimated  to       clinical  signs and symptoms, laboratory  and
           have  a lifetime risk of developing  PAH. Despite    echocardiography  findings,  and  concomitant
           treatment  with pulmonary  vasodilators,  patients   diseases were evaluated.  The determinants  of
           with SSc-PAH have a high mortality rate [13].        the  study  were  signs  of  excessive  fibrosis  (skin
              Although the etiopathogenesis of scleroderma-     lesion  and  pulmonary  fibrosis),  vasculopathy
           like  conditions  in DM is associated  with          (hypertension  and  proteinuria),  and  inflammation
           non-enzymatic  glycation  of  collagen,  it  has  not   (arthritis and elevated  C-reactive  protein [CRP],
           been established. High blood glucose levels          erythrocyte   sedimentation    rate   [ESR],   or
           can  stimulate  the  proliferation  of  fibroblasts   rheumatoid factor [RF]). This study was approved
           and the production of other extracellular  matrix    by the Local Ethics Committee.

                                                    ©2023 AccScience Publishing
   24   25   26   27   28   29   30   31   32   33   34